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The insulin-stimulated cyclic AMP phosphodiesterase from liver plasma membranes is shown to be 
activated upon incubation with guanine nucleotides in the presence of ATP. The non-hydrolysable 
analogue of ATP, adenylyl imidodiphosphate failed to substitute for ATP in achieving activation. GTP, 
its non-hydrolysable analogues p[NHJppG and GTP-y-S, as well as GDP, all elicited activation. It is 
suggested that guanine nucleotides, and probably insulin, exert their effect on this enzyme through a 
distinct species of guanine nucleotide regulatory protein. 
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1. INTRODUCTION 
Many cellular functions are regulated by altera- 
tions in intracellular cyclic AMP concentrations 
[l]. In liver, the only mechanism of degrading 
cyclic AMP is through the action of cyclic AMP 
phosphodiesterases [2-41. These enzymes exist in 
multiple forms within the liver, associated with 
both soluble and membrane-bound fractions 
[2-61. In a variety of tissues the activity of certain 
species is affected by hormones (review [4]). In 
liver (review [4,7,8]) the activity of two distinct 
membrane-bound species can be modulated by 
glucagon and insulin in intact hepatocytes [7,8]. 
nucleotide regulatory proteins [ 15,161. Further- 
more, a high affinity cyclic GMP phosphodie- 
sterase in rod outer segments is light-activated 
through a process involving rhodopsin and a 
distinct guanine nucleotide regulatory protein 
[17-201. 
Here, we show that guanine nucleotides elicit an 
activation of the peripheral, liver plasma mem- 
brane, cyclic AMP phosphodiesterase. 
2. MATERIALS AND METHODS 
In purified liver plasma membranes, insulin can 
activate a high affinity peripheral cyclic AMP 
phosphodiesterase [9-131, which is bound to a 
specific, integral protein site on the plasma mem- 
brane [14]. This activation occurs at physiological 
concentrations of insulin [lo] and is due to an 
insulin-triggered phosphorylation of the enzyme 
[ 10,131. However, this enzyme can be activated by 
insulin in intact hepatocytes [7,8]. 
The activation of a number of hormones ap- 
pears to be mediated or modulated by guanine 
Rat liver plasma membranes were prepared 
using a modification of the method in [21]. Male 
Sprague-Dawley rats (225-275 g body wt) were 
used. Typically, 3 rat livers were homogenized 
using 4 strokes of a Teflon-glass homogenizer tak- 
ing 3 vol. liver with 1 vol. 1 mM KHCOs (pH 7.2). 
The homogenate was diluted to 120 ml with 1 mM 
KHCO3 and subsequently centrifuged at 2000 g for 
10 min. The resulting pellet was resuspended to 
-80 ml with 1 mM KHCOr and added to 60 g 
sucrose. This sucrose was dissolved by stirring the 
homogenate for 30 min at 4°C. Plasma mem- 
branes were collected at the 42%48.2% (w/v) 
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sucrose interface during centrifugation at 100 000 
x g for 3 h in a swing out MSE prepsin 3 x 70 ml 
head. These membranes were removed from the 
density gradient and subsequently diluted with an 
equal volume of 1 mM KHCO3. Membranes were 
finally collected by centrifngation at 25 000 x g 
for 10 min and resuspended in 1 mM KHC03 (pH 
7.2) to 15-20 mg/ml prior to storage at - 80°C. 
The in vitro activation and assay of cAMf 
phosph~iester~e were essentially as [lOJ. Briefly 
prior to activation, membranes were diluted with 5 
vol. 0.25 M sucrose containing 3 mM imidazole 
(pH 7.4) and collected by centrifugation at 15000 
x g for 10 min. This washing procedure was 
repeated once before the membranes were 
resuspended in 0.25 M sucrose containing 3 mM 
imidazole (pH 7.4). Aliquots of plasma mem- 
branes (5OOhg protein) were incubated at 3tYC for 
5 min with an activation cocktail containing 
10e4 M cyclic AMP, 4 mM ATP and 5 mM MgCL, 
100 pM CaCh, lO_’ M insulin and 20 mM 
Tris-IX1 (pH 7.4) final corm. All these solutions, 
including the Tris-buffer were made up freshly 
each day. After incubation the membranes were 
rapidly cooled and washed a further twice with 
0.25 M sucrose containing 3 mM imidazole (pH 
7.4). The high affinity peripheral cyclic AMP 
phosphodiesterase was solubilized with 0.4 M 
NaCl prior to assay with 4 x 10m7 M cyclic AMP 
at 30°C for 15 min as in [S]. 
activating this phosphodiesterase in an isolated 
membrane preparation [IO- 131, insulin can also 
activate it in intact hepatocytes 1781. Under such 
conditions we also observed t7,8] a concomitant 
decrease in intracellular cyclic AMP concentra- 
tions. This suggests that the peripheral phospho- 
diesterase may have an important regulatory func- 
tion within the cell. Although activation of this en- 
zyme proceeds via a phosphorylation mechanism 
1133 it is, at present, unclear as to how insulin trig- 
gers this event. However, the enzyme might bind to 
the insulin receptor itself [14]. Occupancy of the 
insulin receptor, by hormone, could then result in 
a conformational change in the associated phos- 
phodiesterase, allowing it to become a substrate 
for phospho~lati~~. 
We show here that guanine nucleotides elicit the 
activation of the peripheral cyclic AMP 
phosphodiesterase from liver plasma membranes 
go76543 076543 
Protein was determined by a modified micro- 
biuret method [22]. Cyclic AMP, ATP, GTP, 
GTI+-S (guanosine- ’ -U-r3-thiotriphosphate~) 
and PNHPPG (guanine 5 ’ -p,y-imidol] 
triphosphate) were purchased from Boehringer 
(Lewes, East Sussex). All other biochemicals in- 
cluding GDP (cat. no. G.6506) were from Sigma 
Chemical Co. (Surrey). Radiochemicals were ob- 
tained from Amersham Internatio~l (Bucks). All 
other chemicals were of AR grade from BDH 
Chemicals (Poole, Dorset). 
0 
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3. RESULTS AND DISCUSSION -log fguanine nucteotide I M 
Insulin can cause the p~ospho~lati~~ and ac- 
tivation of a high affinity cyclic AMP 
phosphodiesterase associated with liver plasma 
membranes [lo-131. This enzyme is a peripheral 
protein [5], which appears to bind to a specific in- 
tegral protein within the membrane [141  AS well a~ 
Fig. 1. Guanine nucleotide activation of plasma mem- 
brane phosphodiesterase. Activations and assay of the 
peripheral cyclic AMP phosphodiesterase were perform- 
ed as in section 2. Results are the average of 3 expt. 
Guanine nucleotides used were: (a) GTP; [b) GDP; (c) 
PPWPPG; f4 GTPr-S- 
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Table 1 
Effect of guanine nucleotides on the activation of the 
peripheral, liver plasma membrane phosphodiesterase 
(activity, % of control) 
Ligand Guanine nucleotide, 
final cont. 
1O-6 M 1O-4 M 
GTP 115* 4 136 f 6 
GTP + insulin 131 * 8 156 f 5 
GDP 125* 5 172 f 3 
GDP + insulin 120+ 6 144 f 5 
GTP-y-S 14Ok 6 157 f 5 
GTP-y-S + insulin 168k 4 190 f 4 
PN-UPPG 141 f 4 157 f 3 
p[NH]ppG + insulin 182 * 10 229 i 4 
The results are the average of 3 expt. done using a single 
membrane preparation (errors are f SD). This typifies 
the results that were obtained using 3 different mem- 
brane preparations inall. In this instance insulin elicited 
at 130 f 5% activation of the peripheral plasma mem- 
brane phosphodiesterase. Activations and phospho- 
diesterase assay were done as in section 2 
(fig. 1, table 1). This process is presumably 
mediated through the phosphorylation of the en- 
zyme as adenylyl imidodiphosphate, a non- 
hydrolysable analogue of ATP, failed to substitute 
for ATP in achieving activation. Furthermore, 
GTP does not appear to act as the phosphate 
donor as p[NH]ppG and GTP-y-S both caused the 
activation of this enzyme when ATP was present. 
In each case the degree of activation elicited by the 
guanine nucleotides was dose dependent, although 
mM levels of these nucleotides, especially the non- 
hydrolysable analogues tended to block the 
response (fig. 1). 
Interestingly, GDP was quite as effective as 
GTP, if not more so, in activating the enzyme 
(table 1). However, there was no observable effect 
of insulin in activating the enzyme when GDP was 
present. This contrasts with a small effect seen 
with GTP and near additive or synergistic effects 
observed using the two non-hydrolysable GTP 
analogues, p[NH]ppG and GTPT-S (table 1). 
These observations bear analogy with the light 
activation of the high affinity cyclic GMP 
phosphodiesterase in rod outer segments [17-201. 
It is also a peripheral protein which associates with 
the membrane through binding to integral pro- 
tein(s) rather than any lipid interaction [17]. Here, 
the photo-excitation of rhodopsin elicits the activa- 
tion of this enzyme in a guanyl nucleotide- 
mediated process [17-201. The mechanism of this 
activation is unknown, no evidence having been 
provided to suggest hat a phosphorylation step is 
involved [ 17,23,24]. However, rhodopsin does 
trigger the light-activated phosphorylation of a 
number of proteins [23-261, an effect which can be 
enhanced by GTP [24]. 
The peripheral, liver plasma membrane 
phosphodiesterase could also be activated through 
a process involving a guanine nucleotide regulatory 
protein. Indeed, treatment of hepatocytes with just 
cholera toxin, which is known to specifically 
modify guanine nucleotide regulatory proteins 
[16], activates this enzyme (unpublished). Cholera 
toxin has also been shown to elicit the activation of 
the retinal enzyme in the absence of light [27]. The 
Ka for GTP-activation of the retinal phospho- 
diesterase [ 191 is very similar to that we observe for 
the liver enzyme (3-5/1M, range, n = 3). Further- 
more, in both systems ([19] fig. l), the Ka for ac- 
tivation by the non-hydrolysable analogues of 
GTP (0.5-l PM, range n = 3) are considerably 
lower than for GTP itself. However, the retinal en- 
zyme may be activated by a guanine nucleotide 
regulatory protein that expresses GTPase activity 
[17-201. Thus it is assumed [17-20,281 that GDP 
would not activate the enzyme. This is in contrast 
with the liver phosphodiesterase activated by GDP 
(table 1, fig. 1). However, in liver, guanine 
nucleotide regulatory protein(s) acting on 
adenylate cyclase can be activated by GDP under 
conditions where no transphosphorylation exists 
[29,30]. We see here (fig. 1) that GDP is a more ef- 
fective activator of the phosphodiesterase than 
GTP. Thus the binding of guanine nucleotides 
themselves might elicit changes in the functioning 
of the regulatory protein, rather than it being 
achieved by GTP hydrolysis. 
In liver plasma membranes [l&16], glucagon ex- 
erts its activating effect on adenylate cyclase 
through a stimulatory guanine nucleotide 
regulatory protein (N,). This protein (NJ is unlike- 
ly to be a candidate for action on the phospho- 
diesterase as glucagon does not activate the 
phosphodiesterase in either broken membranes 
[lo] or in intact cells [7,8]. Indeed the K, for GTP, 
89 
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expressed by glucagon-stimulated adenylate 
cyclase is of the order of 0.05-o. 1 ,uM [31-331. 
This is very different from the &values of 3-5 ,uM 
we observe for GTP/GDP activation of the 
phosphodiesterase. However, as well as the so- 
called N, regulatory proteins, a family of distinct 
guanine nucleotide regulatory proteins (Ni) have 
been identified based upon their ability to mediate 
inhibitory responses on adenylate cyclase [ 151. 
These proteins (Ni) have an affinity for GTP which 
is around two orders of magnitude lower than that 
exhibited by N, [15,34,35]. Furthermore, this 
species appears to exhibit a considerably higher af- 
finity for the non-hydrolysable analogues of GTP 
than for GTP itself [36,37], which is in accord with 
our observations (fig. 1) of their ability to activate 
the liver phosphodiesterase. As multiple species of 
guanine nucleotide regulatory proteins appear to 
exist in liver plasma membranes [15] it is possible 
that the activation of the phosphodiesterase we 
observe is mediated by a guanine nucleotide pro- 
tein with the characteristics of Ni. 
It remains to be seen whether insulin’s activation 
of the peripheral phosphodiesterase is also 
mediated via a guanine nucleotide regulatory pro- 
tein. Certainly one can draw an analogy with the 
light activation of retinal phosphodiesterase, 
where the involvement of such a regulatory protein 
has been clearly demonstrated [17-201. In sar- 
colemma membranes [38], insulin causes the ATP- 
dependent phosphorylation of membrane proteins 
through a GTP-requiring process. We have 
demonstrated ([7,8], unpublished) that in intact 
hepatocytes the ability of insulin to activate the 
peripheral phosphodiesterase is either severely 
reduced or blocked by treatments which modify 
guanine nucleotide regulatory proteins. Therefore, 
insulin may exert certain of its cellular effects 
through guanine nucleotide regulatory proteins. 
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